This inventor holds 1 USPTO granted patent. Top assignee: Klinge Pharma Gmbh. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: The Innovations of Peter Jank
Introduction
Peter Jank is a notable inventor based in Hofolding, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his work on p-Oxybenzoic acid derivatives. His innovative approach has led to advancements in drug development with hypolipemic properties.
Latest Patents
Peter Jank holds 1 patent for his work on p-Oxybenzoic acid derivatives. This patent details a process for the preparation of these compounds and their physiologically compatible salts, as well as their enantiomeric and diastereomeric forms. These derivatives are recognized for their potential in creating drugs that effectively lower lipid levels in the body.
Career Highlights
Jank is currently associated with Klinge Pharma GmbH, where he continues to explore and develop pharmaceutical innovations. His work has been instrumental in advancing the understanding of hypolipemic agents and their applications in medicine.
Collaborations
Throughout his career, Peter Jank has collaborated with esteemed colleagues such as Friedemann Reiter and Michael Schliack. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Peter Jank's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key figure in drug development. His work continues to impact the industry positively, paving the way for future advancements in hypolipemic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile